PatientPoint
PatientPoint provides digital health content at the point of care through its network of waiting and exam room screens.
Secondary Market Price
How PatientPoint Measures Up
To help you manage your PatientPoint equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
TBD
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of PatientPoint's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future PatientPoint Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for PatientPoint's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
PatientPoint operates a digital screen network located at the point of care, delivering health-related content to patients and medical providers. The company's services include providing digital screens and engagement tools for waiting rooms, exam rooms, and staff meeting areas, in addition to mobile and patient portal targeting. These offerings are utilized by healthcare providers and brands in sectors like pharmaceuticals and consumer health to inform patient decisions and track business outcomes. Information regarding the company's founding date and founders is not detailed in available materials, but a key milestone has been its growth into the largest digital screen network in its category.
A recent major announcement for the company was its acquisition by Advent International. While PatientPoint has not outlined specific future plans, this development indicates a potential for continued expansion. The company quantifies its impact with data showing improved health outcomes where its products are used, including a reported 45% increase in mammograms and a 20% increase in colon cancer screenings.
- Advent International
- L Catterton
- Littlejohn & Co.
- Searchlight Capital Partners
- Silver Point Capital
- Co-Founder, CEO Brain Schimpf
- Co-Founder, Mike Collette
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is PatientPoint worth joining?
Evaluating an offer from a private company like PatientPoint requires analyzing the potential of its equity compensation. Tools like Prospect can help you project the future value of your equity by using data-driven models similar to those used by venture capitalists.
What should I do with my PatientPoint stock?
Managing private company stock involves creating a strategy for exercising options and selling shares to maximize your post-tax value. Platforms like Prospect offer personalized strategies and tax optimization tools to help you make informed decisions about your PatientPoint equity.
Can you sell PatientPoint stock?
As a private company, PatientPoint stock is not traded on a public exchange, but it can often be sold through secondary markets or company-organized tender offers. Prospect provides tools to help you navigate these sales and determine which shares are the most tax-optimal to sell.
How can I find the value of my PatientPoint stock?
Valuing private stock is complex, but you can get a data-driven estimate using specialized platforms. Prospect uses proprietary predictive models to forecast the future value of your shares, helping you understand what your PatientPoint equity could be worth.
What is PatientPoint's equity worth?
The exact value of private equity fluctuates, but its potential worth can be projected based on various company and market signals. You can use a platform like Prospect to upload your equity details and receive a customized forecast for your PatientPoint holdings based on their machine learning models.
What is PatientPoint's stock ticker symbol?
PatientPoint is a private company, so it does not have a stock ticker symbol and is not traded on public stock exchanges. Ticker symbols are only assigned to companies once they become publicly listed through an initial public offering (IPO).
Can I buy or sell PatientPoint stock?
Selling private stock like PatientPoint's is possible through secondary markets or tender offers, while buying is typically restricted to accredited investors or employees. Tools like Prospect can help you optimize selling decisions but do not act as a broker for buying or selling shares directly.
What is the criteria to buy or invest in PatientPoint stock?
Investing in a private company like PatientPoint is typically limited to accredited investors participating in funding rounds or employees exercising their stock options. The specific criteria are set by the company and securities regulations, not by third-party platforms.
